Publicaciones en colaboración con investigadoras/es de Charing Cross Hospital (2)

2009

  1. Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results

    Multiple Sclerosis, Vol. 15, Núm. 2, pp. 219-228

2005

  1. MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)

    Multiple Sclerosis, Vol. 11, Núm. 4, pp. 433-440